Buy Stocks Easy | About Us
September 25, 2020
Buy Stocks Easy | Online Stocks

SUPN


Buy Supernus Pharmaceuticals, Inc. Stock (symbol: SUPN) Easy Online

Company Name: Supernus Pharmaceuticals, Inc.

Symbol: SUPN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2012

SUPN Current Share Price

Today's SUPN ( Supernus Pharmaceuticals, Inc. ) opening price: $23.5300

Yesterday's SUPN ( Supernus Pharmaceuticals, Inc. ) closing price: $23.4900

Supernus Pharmaceuticals, Inc. Stock ( symbol: SUPN ) Price Chart since IPO (2012):

12 Months Supernus Pharmaceuticals, Inc. Stock ( symbol: SUPN ) Price Chart

Popular Questions about Supernus Pharmaceuticals, Inc. Public Stock ( SUPN )

A: Supernus Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is SUPN

A: Supernus Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2012

A: Supernus Pharmaceuticals, Inc.'s stock (SUPN symbol) price at ther IPO (initial Public Offering) was $23.5300

Q: Is SUPN stock worth buying at the moment?

A: The SUPN stock performance since 2019 are rather disappointing. If you had bought 1 share of Supernus Pharmaceuticals, Inc. stock (symbol: SUPN) at the beginning of 2019, at the opening share price of $38.1300, you would be left with exactly $23.5300 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Supernus Pharmaceuticals, Inc. Stock Easy Online

Supernus Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Supernus Pharmaceuticals, Inc. Stock Price Yesterday



 


Supernus Pharmaceuticals, Inc. Stock Price – Last Week




 


Supernus Pharmaceuticals, Inc. Stock Price – Last Month




 


Supernus Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958212/0/en/Supernus-Provides-Update-on-Results-from-Phase-III-Study-P301-of-SPN-810-for-Treatment-of-Impulsive-Aggression-IA-in-ADHD-Patients.html
                            

                                
Supernus Provides Update on Results from Phase III Study (P301) of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients

                                
                                
ROCKVILLE, Md., Dec.  09, 2019  (GLOBE NEWSWIRE) -- Supernus Pharma...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/11/1944943/0/en/Supernus-Submits-New-Drug-Application-for-SPN-812-for-the-Treatment-of-ADHD.html
                            

                                
Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD

                                
                                
SPN-812 (viloxazine hydrochloride), a novel serotonin norepinephrin...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4303262-supernus-pharmaceuticals-inc-supn-ceo-jack-khattar-q3-2019-results-earnings-call-transcript
                            

                                
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2019 Results - Earnings Call Transcript

                                
                                
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2019 R...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/605285/supernus-pharmaceuticals-supn-q3-earnings-and-revenues-lag-estimates
                            

                                
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Lag Estimates

                                
                                
Supernus (SUPN) delivered earnings and revenue surprises of -8.47% ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/24/1935355/0/en/Supernus-to-Host-Third-Quarter-2019-Earnings-Conference-Call.html
                            

                                
Supernus to Host Third Quarter 2019 Earnings Conference Call

                                
                                
ROCKVILLE, Md., Oct.  24, 2019  (GLOBE NEWSWIRE) -- Supernus Pharma...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4296913-supernus-pharmaceuticals-solid-bet-year-end
                            

                                
Supernus Pharmaceuticals: Solid Bet Into Year End

                                
                                
Today, we revisit Supernus Pharmaceuticals, whose stock is down jus...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/946166/5-health-care-stocks-gurus-are-buying
                            

                                
5 Health Care Stocks Gurus Are Buying

                                
                                
According to the GuruFocus All-In-One Screener as of Friday, the fo...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/936977/supernus-pharmaceuticals-inc-supn-president-ceo-jack-a-khattar-bought-190008-of-shares
                            

                                
Supernus Pharmaceuticals Inc (SUPN) President, CEO Jack A. Khattar Bought $190,008 of Shares

                                
                                
President, CEO of Supernus Pharmaceuticals Inc (30-Year Financial, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958212/0/en/Supernus-Provides-Update-on-Results-from-Phase-III-Study-P301-of-SPN-810-for-Treatment-of-Impulsive-Aggression-IA-in-ADHD-Patients.html
                            

                                
Supernus Provides Update on Results from Phase III Study (P301) of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients

                                
                                
ROCKVILLE, Md., Dec.  09, 2019  (GLOBE NEWSWIRE) -- Supernus Pharma...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/11/1944943/0/en/Supernus-Submits-New-Drug-Application-for-SPN-812-for-the-Treatment-of-ADHD.html
                            

                                
Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD

                                
                                
SPN-812 (viloxazine hydrochloride), a novel serotonin norepinephrin...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4303262-supernus-pharmaceuticals-inc-supn-ceo-jack-khattar-q3-2019-results-earnings-call-transcript
                            

                                
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2019 Results - Earnings Call Transcript

                                
                                
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2019 R...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/605285/supernus-pharmaceuticals-supn-q3-earnings-and-revenues-lag-estimates
                            

                                
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Lag Estimates

                                
                                
Supernus (SUPN) delivered earnings and revenue surprises of -8.47% ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/24/1935355/0/en/Supernus-to-Host-Third-Quarter-2019-Earnings-Conference-Call.html
                            

                                
Supernus to Host Third Quarter 2019 Earnings Conference Call

                                
                                
ROCKVILLE, Md., Oct.  24, 2019  (GLOBE NEWSWIRE) -- Supernus Pharma...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4296913-supernus-pharmaceuticals-solid-bet-year-end
                            

                                
Supernus Pharmaceuticals: Solid Bet Into Year End

                                
                                
Today, we revisit Supernus Pharmaceuticals, whose stock is down jus...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/946166/5-health-care-stocks-gurus-are-buying
                            

                                
5 Health Care Stocks - Gurus Are Buying

                                
                                
According to the GuruFocus All-In-One Screener as of Friday, the fo...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/936977/supernus-pharmaceuticals-inc-supn-president-ceo-jack-a-khattar-bought-190008-of-shares
                            

                                
Supernus Pharmaceuticals Inc (SUPN) President, CEO Jack A. Khattar Bought $190,008 of Shares

                                
                                
President, CEO of Supernus Pharmaceuticals Inc (30-Year Financial, ...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.